325 Capital’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,144,502
Closed -$18.6M 9
2023
Q2
$18.6M Hold
1,144,502
12.23% 4
2023
Q1
$19.9M Hold
1,144,502
17.41% 3
2022
Q4
$21.5M Hold
1,144,502
23.28% 1
2022
Q3
$20.3M Hold
1,144,502
23.64% 1
2022
Q2
$20M Hold
1,144,502
18.51% 1
2022
Q1
$23.9M Buy
1,144,502
+231,394
+25% +$4.43M 18.16% 1
2021
Q4
$16.2M Buy
+913,108
New +$14.7M 15.95% 1

Other funds holding NXGN

325 Capital's NXGN Position: Q3 2023 in Review

325 Capital sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2023, closing a stake of 1,144,502 shares — an estimated $18.6M sold.

325 Capital first reported a position in NXGN in Q4 2021 and held it in 7 quarters. The position peaked at $23.9M in Q1 2022. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.

  • 325 Capital reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • 325 Capital sold 1,144,502 NextGen Healthcare, Inc. Common Stock shares in Q3 2023, an estimated $18.6M.
  • 325 Capital first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • 325 Capital's NextGen Healthcare, Inc. Common Stock position peaked at $23.9M in Q1 2022.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.

Based on 325 Capital's 13F filing for Q3 2023, filed 14 Nov 2023.